Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

In response to the COVID-19 pandemic, our team will be interviewing experts from across the ecosystem to bring the HLTH community timely facts and updates. Frank Rivera: Patient Advocate- Fight for those who can&#39;t fight for themselves! Frank Rivera founded Sarcoidosis of Long Island in 2012. In 2011 Frank was diagnosed with Sarcoidosis after being misdiagnosed with lung cancer for 7 years prior. Since opening Sarcoidosis of Long Island he has been a local, state and federal advocate for Sarcoidosis. Frank strives to raise awareness for Sarcoidosis nationally, but specifically in the government sector. He has represented the Rare and Sarcoidosis community as a speaker at two Congressional briefings for Sarcoidosis. https://twitter.com/SarcofI Kristal Kent: Kristal is a Patient Advocate for the Fibromyalgia, Veteran, Chronic Pain and Chronic Illnesses Communities. Utilizing social media, Kristal educates and provides support for her communities. Kristal serves on the Cleveland Clinic Patient Panel and a Board Of Trustee for the Fibromyalgia Care Society Of America. The Fibromyalgia Pain Chronicles: https://www.facebook.com/FibrolPainChronicles/ Candace Lerman: Candace Lerman, Esq., is an attorney, consultant, and author of the rare disease blog, RareCandace.com. She earned her Juris Doctorate with a concentration in Health Law at the Shepard Broad School of Law at Nova Southeastern University in Fort Lauderdale, Florida and a certificate in Healthcare Compliance from Seton Hall University School of Law. In addition, she holds a Bachelor’s and Master’s degree in International Affairs from Florida State University. A rare disease patient, Candace researched and repurposed a drug to put her blood disorder into remission twice! She works closely with members of Congress on federal healthcare policy, and can often be found on Capitol Hill meeting with staff on various topics involving health policy. Candace serves on the board of Our Odyssey, an organization dedicated to fostering support and community among young adults living with rare and chronic conditions. https://twitter.com/RareCandace

COVID-19 Discussion with Patient Advocates

Blog - 0020

In response to the COVID-19 pandemic, our team will be interviewing experts from across the ecosystem to bring the HLTH community timely facts and updates. About Mario Schlosser:  Mario Schlosser is the CEO and co-founder of Oscar, a health-insurance start-up that is using technology, design, and data to help humanize and simplify healthcare. Previously, he co-founded the largest social gaming company in Latin America, where he led the company’s analytics and game design practices. At Bridgewater Associates, Mario developed analytical trading models as a Senior Investment Associate. Prior to Bridgewater, he worked as a consultant for McKinsey &amp; Company in Europe, the U.S. and Brazil. As a visiting scholar at Stanford University, Mario wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed an algorithm to securely compute trust in randomized networks.

COVID-19 Discussion with Mario Schlosser

Blog - 0033

The cost of weight-loss medications is downright tricky. Wondr Health Chief Executive Officer Scott Paddock shares what employers need to know to stay ahead of the curve in achieving long-term clinical outcomes and cost savings.  As CEO, employee health is a top priority. It is critical to leading a high-performing organization and managing healthcare costs. This perspective helps me understand the unique challenge employers face when it comes to covering new and costly weight-loss medications to treat obesity.  With the demand for newer GLP-1 medications such as Wegovy, Ozempic, and (soon) Mounjaro soaring, the potential cost fallout has become an increasing concern for both self-insured employers and health plans. Many organizations are facing a critical decision right now: to foot or not to foot the weight-loss medication bill.  So, what is the best way to simultaneously offer treatment for obesity and obesity-related diseases and responsibly manage the economic burden? Rather than excluding weight-loss medications entirely, a strategic plan design can offer the best of both worlds. With the following guidelines and expert guidance from a proven partner, organizations can implement a cost-effective and clinically impactful obesity management benefit: <ol><li>Require engagement in a comprehensive behavior change program to drive sustainable outcomes: While GLP-s are game changers, they do not address underlying behaviors, which often are the root cause of weight gain, and anyone who discontinues a weight-loss medication without additional support is likely to regain weight. Adding a comprehensive behavioral change program can lead to sustained weight loss, improved physical health, and increased quality of life. Requiring participant engagement for prescription refills also ensures patient safety. </li><li>Employ a rigorous clinical management model &amp; trusted prescribing partner to promote better outcomes &amp; contain costs:</li></ol><ul><li>Develop an open formulary for tailored prescribing: There are many affordable weight-loss medications outside of GLP-1s that have been around for years. It is important to leverage the full range of weight-loss medications, not just GLP-1s, to ensure individuals get the right treatment based on their unique needs. Not using the full-spectrum of weight-loss medications can be both clinically detrimental and unnecessarily costly. <ul><li>Consider a step-therapy approach: There is no &quot;one-size-fits-all&quot; approach to weight-loss medication, and GLP-1s shouldn’t necessarily be the first resort. Consider using GLP-1s only when other medication protocols have failed and prescribe the most cost- and clinically effective drug, considering the patient’s whole health.</li><li>Evaluate eligibility criteria: Even outside of the strict criteria that individuals must meet to be considered eligible for a prescription, GLP-1s aren’t the right choice for everyone. Consider offering this class of drugs only to the most acute participants in your population. When prescribing weight-loss medication, a provider also should consider co-morbidities, contraindications, drug indications, and more affordable alternatives to ensure optimal results for every patient.</li></ul></li></ul> 3. Leverage reporting and tracking to ensure impact and results: Ongoing monitoring helps manage patient safety and tracks positive health outcomes like weight loss over time, engagement with the behavior change program, clinical and medication adherence, and improvements in musculoskeletal pain, stress, and sleep.  In this new frontier of obesity treatment, weight-loss medications can make a meaningful difference in managing obesity and its related health concerns and costs. By using these guidelines, organizations can reduce the potential costs of weight-loss medications while also improving the health and lives of their people.  For a closer look into leveraging a successful obesity management program, download the <a href="https://1751431.fs1.hubspotusercontent-na1.net/hubfs/1751431/B2B/Wondr%20Advanced/W3129_employer%20guide_Obesity%20Management%20Program%20Best%20Practices.pdf" target="_blank">Obesity Management Program Best Practices Guide</a> for employers.  Learn more about our solution, <a href="https://go.wondrhealth.com/wondr-advanced" target="_blank">Wondr Advanced</a>, the advanced obesity solution to help organizations navigate the complexities of weight-loss medications to optimize outcomes and control costs.

Worried About the Cost of Weight-Loss Medications? Here is What Employers Need to Know

Blog - 0192

Global Healthcare Solutions Lead

Healthcare is elemental to society — it’s a timeless yet ever-evolving practice. And like every other industry, it has experienced sweeping changes–over the past few years in particular. With digital transformation empowering health organizations to embrace a more connected, efficient way of doing things, both providers’ and patients’ experiences have been elevated by the strategic application of technology.  The <a href="https://www.hlth.com/2022event" target="_blank">HLTH 2022</a> event reflects on the impact of these changes, as well as discusses what’s next — for technology organizations, healthcare providers, and patients.  Taking place Nov. 13-16, 2022 in Las Vegas, HLTH helped connect people and highlight important industry voices. Here’s a quick snapshot of Zoom’s participation:  Chatting with Moderna about preventative healthcare Ron Emerson, Zoom’s Global Healthcare Lead, sat down with Shannon Klinger, Chief Legal Officer at Moderna, for a fireside chat about increasing access to preventative care. Titled, “How Technology Is Powering Equitable Access to Preventative Health,” the session featured Ron and Shannon sharing their thoughts on how the COVID-19 pandemic changed how people approach disease prevention and equity of care. They reflect that the rapid technological change during the pandemic drove a fundamental shift in the healthcare ecosystem, creating new opportunities for patients to seek proactive care and participate in wellness education. Beyond baseline employee benefits  Healthcare often means a lot more than a routine physical or trip to the dentist, and your workforce expect you to understand their needs — and tailor benefits accordingly. For example, mental health benefits are important to younger employees. Today’s workers are looking for “a lot more than kombucha on tap,” as Zoom’s Global Head of Benefits, Sheila Krueger, remarked during her session at HLTH. To attract and motivate Millennial and Gen Z talent — an <a href="https://www.computerworld.com/article/3661170/what-gen-z-and-millennials-want-from-employers.html" target="_blank">increasingly good chunk of today’s workforce </a>— companies need to understand the importance of company culture. Motivated by more than just money, these workers are looking for a sense of belonging and purpose, and want to identify their “why” when working for an organization. That’s why, Sheila explained, your culture needs to shift its focus onto mental health, inclusivity, community, and a strong mission — or be prepared potentially be prepared to fall victim to <a href="https://www.forbes.com/sites/forbesbusinesscouncil/2022/10/24/meaningful-work-why-your-people-are-quiet-quitting-and-what-to-do-about-it/?sh=5c60f5d49280" target="_blank">“quiet quitting.” </a> One platform to create better healthcare experiences  To get a better grasp of how Zoom can help enhance provider and patient experiences, we demonstrated several important features of the service for healthcare users: <ul><li>Use one platform to meet administrative, medical education, and virtual care communication needs</li><li>Optimize existing healthcare workflows with our current apps and integrations, or discover how to develop a custom solution </li><li>Take telemedicine visits to new heights </li><li>Add cloud-based phone and contact center capabilities to healthcare communications</li></ul> Supporting our partners The icing on top of an already great event? Zoom’s partner <a href="https://partner.zoom.us/solutions/isv/docusign/" target="_blank">DocuSign</a> hosted a booth of their own during the event, where they demonstrated how the Zoom integration enables a seamless telehealth session, and showed how DocuSign solutions can improve operational efficiency and elevate patient experiences. Ron Emerson discussed the enthusiasm around the integration, explaining, “Through Zoom Apps, our healthcare users can process clinical and business workflows and documentation right from a Zoom Meeting. This powerful tool allows patients and healthcare professionals the ability to complete business and clinical documentation in a frictionless manner.”   Discover more insights HLTH comes right on the heels of Zoom’s our annual user conference,Zoomtopia, where we reflected on providers&#39; and patients’ ever-evolving relationship with digital healthcare, and what Zoom is doing to help elevate healthcare experiences for all. To uncover expert insights, exciting product announcements, and more, be sure to check out our <a href="https://events.zoom.us/ev/AmI6_1Mt8-7eDXMuTIJfdjzFJe-YPfJzAcEi9TRMzCUeedRviNuI~AoCZrVz5GKkRySO4wZ0zOTqlTK5vlam_IeCNp-xGZ9E9NujzLlw7bbV5-g" target="_blank">Zoomtopia 2022 on-demand recordings. </a>

Elevating Access and Delivery of Care: Insights from HLTH Conference 2022

Blog - 0139